Clinical trial Recruiting at 1 site Interventional Ages 19 to 80

Effects of Wood Smoke on Lung Health in Adults

Official title: Lungs on Fire: Wildfire Smoke, Incident Diseases, Susceptible Populations, and Community Values in Canada

Run by University of British Columbia · NCT07536178 · Data updated 2026-11-12

This study tests how different levels of woodsmoke exposure affect lung function and inflammatory responses in healthy adults.

Quick facts

Study typeInterventional
Ages19 Years to 80 Years
SexAll
Enrollment24 (estimated)
SponsorUniversity of British Columbia
Academic / other
Locations1 site (Vancouver, British Columbia)
StatusRecruiting
StartedMay 26, 2026
Main results expectedAugust 31, 2029
Study endsAugust 31, 2030
Registry record updatedOctober 26, 2026
Trial IDNCT07536178 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy adults 19–80 years old without current or past respiratory diseases or confounding medical conditions, and not pregnant.

Probably not a fit

Individuals with current respiratory illnesses or certain comorbidities may not benefit and could be excluded due to safety considerations.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study uses controlled human exposures to woodsmoke (from Lodgepole Pine) at three concentrations and a filtered-air control to explore potential links between wildfire smoke and chronic lung diseases. Participants are healthy adults aged 19 to 80 and will undergo 2-hour exposure sessions over multiple days with varying PM2.5 levels. The goal is to understand how exposure concentration, intensity, and duration influence lung function, inflammation, and immunomodulatory responses, building biological plausibility for connections to asthma, COPD, and lung cancer. Findings may shed light on which individuals are most vulnerable to wildfire smoke and the mechanisms behind long-term respiratory effects.

Why it matters

Potential benefit: If successful, the study could improve understanding of who is most at risk from wildfire smoke and inform public health guidance and protective strategies.

How similar studies have gone: Previous research in controlled smoke exposures has provided mechanistic insights, though this exact WFS exposure model in healthy adults is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy Adults between the ages of 19 to 80 (12 of each biological sex assigned at birth).

Exclusion Criteria:

1. Current smoker (within six months before screening; potential to confound exposure effects).
2. History or current diagnosis of any respiratory conditions (including, but not limited to asthma or chronic obstructive pulmonary disease (COPD), asthma/COPD overlap) or other medical conditions that the study physician determines may impact participant safety.
3. Any comorbidities or other concerns identified by the study physician which may impact study participation.
4. For participants of child-bearing potential: Current pregnancy, or plans to become pregnant during study enrolment.

Where it's running

  • Air Pollution Exposure Lab
    Vancouver, British Columbia, Canada
    Recruiting

Study contacts

  • Principal investigator: Chris Carlsten, MD, MPH — University of British Columbia
  • Study coordinator: PJ (Parteek) Johal, BCS
  • Email: p.johal@ubc.ca
  • Phone: 604-875-5132

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.